Unknown PHASE2 INTERVENTIONAL 3-arm NCT03893032

Enhancing Operational Performance in Healthy Rested Soldiers With Pharmacological Stimulants

Sponsor: United States Army Aeromedical Research Laboratory

Conditions Cognition

Interventions Modafinil 200mg Placebo mixed amphetamine salts

Updated 6 times since 2019 Last updated: Jul 29, 2019 Started: Jul 17, 2019 Primary completion: Oct 31, 2019 Completion: Oct 31, 2019

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

A PHASE2 clinical study on Cognition, this trial is ongoing. The trial is conducted by United States Army Aeromedical Research Laboratory and has accumulated 6 data snapshots since 2019. Longitudinal tracking of this trial contributes to a broader understanding of treatment development timelines.

Status Flow

Change History

6 versions recorded

Sep 2024 — Present [monthly]

Unknown PHASE2
Jul 2024 — Sep 2024 [monthly]

Unknown PHASE2

Status: Unknown Status → Unknown
Oct 2021 — Jul 2024 [monthly]

Unknown Status PHASE2

Status: Recruiting → Unknown Status
Jan 2021 — Oct 2021 [monthly]

Recruiting PHASE2
Aug 2019 — Jan 2021 [monthly]

Recruiting PHASE2

Status: Not Yet Recruiting → Recruiting

▶ Show 1 earlier version

Apr 2019 — Aug 2019 [monthly]

Not Yet Recruiting PHASE2

First recorded

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

United States Army Aeromedical Research Laboratory

Data source: United States Army Aeromedical Research Laboratory

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Fort Rucker, United States